A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices.

ABSTRACT:

Background/objectives

A knowledge gap persists regarding anticoagulation therapy after endovascular stent insertion for malignant superior vena cava obstruction (mSVCO). Guidelines are supported by retrospective studies with a radiological focus and lack specific drug recommendations. No studies to date have captured the multi-disciplinary nature of decision-making over time.

Methods

This single-center retrospective service evaluation includes patients with solid organ malignancy who received a stent for mSVCO between July 2016 and May 2022. Patient and treatment characteristics, clinical outcomes and prescribing decisions were collected from medical records and analyzed.

Results

Of 49 patients (55% female, mean age 59), 73% had metastatic extra-thoracic disease at st

SUBMITTER: Walker J 

PROVIDER: S-EPMC12651178 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature